339 related articles for article (PubMed ID: 17504043)
1. Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004).
Théon AP; Wilson WD; Magdesian KG; Pusterla N; Snyder JR; Galuppo LD
J Am Vet Med Assoc; 2007 May; 230(10):1506-13. PubMed ID: 17504043
[TBL] [Abstract][Full Text] [Related]
2. Use of cisplatin-containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000-2004).
Hewes CA; Sullins KE
J Am Vet Med Assoc; 2006 Nov; 229(10):1617-22. PubMed ID: 17107319
[TBL] [Abstract][Full Text] [Related]
3. Comparison of perioperative versus postoperative intratumoral administration of cisplatin for treatment of cutaneous sarcoids and squamous cell carcinomas in horses.
Théon AP; Pascoe JR; Galuppo LD; Fisher PE; Griffey SM; Madigan JE
J Am Vet Med Assoc; 1999 Dec; 215(11):1655-60. PubMed ID: 14567430
[TBL] [Abstract][Full Text] [Related]
4. Perioperative intratumoral administration of cisplatin for treatment of cutaneous tumors in equidae.
Théon AP; Pascoe JR; Meagher DM
J Am Vet Med Assoc; 1994 Oct; 205(8):1170-6. PubMed ID: 7890578
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intratumoral administration of cisplatin versus bleomycin for treatment of periocular squamous cell carcinomas in horses.
Théon AP; Pascoe JR; Madigan JE; Carlson G; Metzger L
Am J Vet Res; 1997 Apr; 58(4):431-6. PubMed ID: 9099393
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral chemotherapy with cisplatin in oily emulsion in horses.
Théon AP; Pascoe JR; Carlson GP; Krag DN
J Am Vet Med Assoc; 1993 Jan; 202(2):261-7. PubMed ID: 8428832
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of equine sarcoids with cisplatin in arachid oil: a useful alternative?].
Spoormakers TJ; Klein WR; van Weeren PR
Tijdschr Diergeneeskd; 2002 Jun; 127(11):350-4. PubMed ID: 12073779
[TBL] [Abstract][Full Text] [Related]
9. Electrochemotherapy as a single or adjuvant treatment to surgery of cutaneous sarcoid tumours in horses: a 31-case retrospective study.
Tozon N; Kramaric P; Kos Kadunc V; Sersa G; Cemazar M
Vet Rec; 2016 Dec; 179(24):627. PubMed ID: 27758950
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases.
Tamzali Y; Borde L; Rols MP; Golzio M; Lyazrhi F; Teissie J
Equine Vet J; 2012 Mar; 44(2):214-20. PubMed ID: 21793876
[TBL] [Abstract][Full Text] [Related]
11. Neoplasms of Equidae.
Sundberg JP; Burnstein T; Page EH; Kirkham WW; Robinson FR
J Am Vet Med Assoc; 1977 Jan; 170(2):150-2. PubMed ID: 576219
[TBL] [Abstract][Full Text] [Related]
12. Indications for and short- and long-term outcome of permanent tracheostomy performed in standing horses: 82 cases (1995-2005).
Chesen AB; Rakestraw PC
J Am Vet Med Assoc; 2008 May; 232(9):1352-6. PubMed ID: 18447781
[TBL] [Abstract][Full Text] [Related]
13. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and survival of horses with ocular/adnexal squamous cell carcinoma: 147 cases (1978-1988).
Dugan SJ; Roberts SM; Curtis CR; Severin GA
J Am Vet Med Assoc; 1991 Jan; 198(2):298-303. PubMed ID: 2004996
[TBL] [Abstract][Full Text] [Related]
15. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
[TBL] [Abstract][Full Text] [Related]
16. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of strontium 90 irradiation in treatment of cutaneous mast cell tumors in cats: 35 cases (1992-2002).
Turrel JM; Farrelly J; Page RL; McEntee MC
J Am Vet Med Assoc; 2006 Mar; 228(6):898-901. PubMed ID: 16536702
[TBL] [Abstract][Full Text] [Related]
18. Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007).
Romanelli G; Marconato L; Olivero D; Massari F; Zini E
J Am Vet Med Assoc; 2008 Apr; 232(8):1193-9. PubMed ID: 18412533
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hypertriglyceridemia and response to treatment with insulin in horses, ponies, and donkeys: 44 cases (1995-2005).
Waitt LH; Cebra CK
J Am Vet Med Assoc; 2009 Apr; 234(7):915-9. PubMed ID: 19335242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
